GREAT POINT PARTNERS LLC
CIK 1281446 · Holdings on Jun 30, 2026 · First reported Aug 14, 2026
Top ten holdings
Q2 2026- VOR7.37%
- ABVX6.41%
- VERA6.07%
- ZURA5.86%
- ALMS5.68%
- SLGL4.79%
- DFTX4.71%
- ANNX4.71%
- ORKA4.11%
- MLTX3.93%
Share classes counted separately53.64%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- VERAWeight increased · +4.11 pp1.96% → 6.07%Shares +401.49K (+201.40%)
- AMLXWeight decreased · -3.00 pp5.96% → 2.96%Shares -1.05M (-60.00%)
- NKTRWeight decreased · -2.70 pp5.58% → 2.88%Shares -141.45K (-44.70%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 25
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | VORVOR BIOPHARMA INCCOM NEW View history and evidence | $31.30M | 7.37% | 1.70M shares | 7.65% → 7.37%-0.28 pp -50.00K (-2.86%) | Reduced | ↗▾ |
| 02 | ABVXABIVAX SA-ADRSPONSORED ADS View history and evidence | $27.23M | 6.41% | 204.31K shares | Prior unavailable +204.31K | New | ↗▾ |
| 03 | VERAVERA THERAPEUTICS INCCL A View history and evidence | $25.78M | 6.07% | 600.84K shares | 1.96% → 6.07%+4.11 pp +401.49K (+201.40%) | Added | ↗▾ |
| 04 | ZURAZURA BIO LTDCLASS A ORD SHS View history and evidence | $24.87M | 5.86% | 4.22M shares | 6.14% → 5.86%-0.28 pp 0 (0.00%) | Unchanged | ↗▾ |
| 05 | ALMSALUMIS INC View history and evidence | $24.09M | 5.68% | 856.06K shares | 4.62% → 5.68%+1.06 pp 0 (0.00%) | Unchanged | ↗▾ |
| 06 | SLGLSOL-GEL TECHNOLOGIES LTDSHS NEW View history and evidence | $20.34M | 4.79% | 274.36K shares | 5.32% → 4.79%-0.53 pp 0 (0.00%) | Unchanged | ↗▾ |
| 07 | DFTXDEFINIUM THERAPEUTICS INCCOM SHS View history and evidence | $19.99M | 4.71% | 425.00K shares | Prior unavailable +425.00K | New | ↗▾ |
| 08 | ANNXANNEXON INC View history and evidence | $19.98M | 4.71% | 3.50M shares | 3.39% → 4.71%+1.32 pp +1.00M (+40.00%) | Added | ↗▾ |
| 09 | ORKAORUKA THERAPEUTICS INC View history and evidence | $17.45M | 4.11% | 183.33K shares | 2.20% → 4.11%+1.91 pp 0 (0.00%) | Unchanged | ↗▾ |
| 10 | MLTXMOONLAKE IMMUNOTHERAPEUTICSCLASS A ORD View history and evidence | $16.66M | 3.93% | 855.81K shares | 2.28% → 3.93%+1.65 pp +355.81K (+71.16%) | Added | ↗▾ |
Options overlay 5
$104.67M notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
ABVXABIVAX SA-ADRSPONSORED ADS View history and evidence | Call | 400.00K | $53.30M | +400.00K | ▾ |
IBRXIMMUNITYBIO INC View history and evidence | Put | 3.00M | $26.27M | 0 (0.00%) | ▾ |
RAREULTRAGENYX PHARMACEUTICAL IN View history and evidence | Put | 600.00K | $20.03M | +600.00K | ▾ |
3 / 5 options · preview only
Exited positions 12
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| APGE APOGEE THERAPEUTICS INC | Non-derivative | -374,000 | -$31.48M | SEC filing ↗ | SEC filing ↗ |
| KALV KALVISTA PHARMACEUTICALS INC | Non-derivative | -675,000 | -$13.59M | SEC filing ↗ | SEC filing ↗ |
| IMVT IMMUNOVANT INC | Non-derivative | -545,625 | -$13.55M | SEC filing ↗ | SEC filing ↗ |
3 / 12 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1281446 · Period 2026-06-30
Data loaded 2026-09-23 · First reported 2026-08-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 529120900
}Research all 42 reported holdings.
This page includes 30 of 42 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 42 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1281446","quarter":"2026Q2","page_size":100}
get_institutional_manager_history
{"cik":"1281446","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.